Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1923 1
1957 1
1962 1
1963 1
1964 1
1967 1
1968 1
1973 1
1974 9
1975 8
1976 10
1977 17
1978 14
1979 18
1980 15
1981 18
1982 18
1983 21
1984 13
1985 21
1986 27
1987 18
1988 19
1989 22
1990 35
1991 23
1992 24
1993 19
1994 20
1995 18
1996 22
1997 20
1998 25
1999 16
2000 21
2001 19
2002 19
2003 15
2004 20
2005 7
2006 11
2007 17
2008 18
2009 10
2010 10
2011 9
2012 6
2013 8
2014 13
2015 13
2016 15
2017 16
2018 15
2019 19
2020 13
2021 15
2022 13
2023 8

Text availability

Article attribute

Article type

Publication date

Search Results

801 results

Results by year

Filters applied: . Clear all
Page 1
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM; Sclerodema Lung Study II Investigators. Tashkin DP, et al. Among authors: wise r. Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25. Lancet Respir Med. 2016. PMID: 27469583 Free PMC article. Clinical Trial.
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.
Long-Term Oxygen Treatment Trial Research Group; Albert RK, Au DH, Blackford AL, Casaburi R, Cooper JA Jr, Criner GJ, Diaz P, Fuhlbrigge AL, Gay SE, Kanner RE, MacIntyre N, Martinez FJ, Panos RJ, Piantadosi S, Sciurba F, Shade D, Stibolt T, Stoller JK, Wise R, Yusen RD, Tonascia J, Sternberg AL, Bailey W. Long-Term Oxygen Treatment Trial Research Group, et al. Among authors: wise r. N Engl J Med. 2016 Oct 27;375(17):1617-1627. doi: 10.1056/NEJMoa1604344. N Engl J Med. 2016. PMID: 27783918 Free PMC article. Clinical Trial.
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
Pascoe S, Barnes N, Brusselle G, Compton C, Criner GJ, Dransfield MT, Halpin DMG, Han MK, Hartley B, Lange P, Lettis S, Lipson DA, Lomas DA, Martinez FJ, Papi A, Roche N, van der Valk RJP, Wise R, Singh D. Pascoe S, et al. Among authors: wise r. Lancet Respir Med. 2019 Sep;7(9):745-756. doi: 10.1016/S2213-2600(19)30190-0. Epub 2019 Jul 4. Lancet Respir Med. 2019. PMID: 31281061 Clinical Trial.
Preface.
Nicolle LE, Wise R, Wood MJ. Nicolle LE, et al. Among authors: wise r. J Antimicrob Chemother. 2000 Aug;46 Suppl A:III. doi: 10.1093/jac/46.suppl_1.0iii. J Antimicrob Chemother. 2000. PMID: 10969056
Preface.
Nicolle LE, Wise R, Wood MJ. Nicolle LE, et al. Among authors: wise r. J Antimicrob Chemother. 2000 Aug;46 Suppl A:1. J Antimicrob Chemother. 2000. PMID: 10969043
Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis.
Fowler VG Jr, Das AF, Lipka-Diamond J, Schuch R, Pomerantz R, Jáuregui-Peredo L, Bressler A, Evans D, Moran GJ, Rupp ME, Wise R, Corey GR, Zervos M, Douglas PS, Cassino C. Fowler VG Jr, et al. Among authors: wise r. J Clin Invest. 2020 Jul 1;130(7):3750-3760. doi: 10.1172/JCI136577. J Clin Invest. 2020. PMID: 32271718 Free PMC article. Clinical Trial.
Cyclophosphamide versus placebo in scleroderma lung disease.
Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M; Scleroderma Lung Study Research Group. Tashkin DP, et al. Among authors: wise r. N Engl J Med. 2006 Jun 22;354(25):2655-66. doi: 10.1056/NEJMoa055120. N Engl J Med. 2006. PMID: 16790698 Free article. Clinical Trial.
MRSA bacteraemia.
Catchpole C, Wise R, Fraise A. Catchpole C, et al. Among authors: wise r. J Hosp Infect. 1997 Feb;35(2):159-61. doi: 10.1016/s0195-6701(97)90105-5. J Hosp Infect. 1997. PMID: 9049821 No abstract available.
Macrolide progress.
Wise R. Wise R. J Antimicrob Chemother. 1990 Jul;26(1):5-6. doi: 10.1093/jac/26.1.5. J Antimicrob Chemother. 1990. PMID: 2145255 No abstract available.
801 results